Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2019 Q1- Text added to 2019 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
abiraterone, accessible, ADC, antagonist, Aurigene, begun, conjugate, docetaxel, emphasized, enzalutamide, Iconic, India, inflammatory, Johnson, Ligand, Minister, modestly, modulate, possession, preexisting, premiership, Prime, purpose, ransomware, rationale, resignation, Russia, structure, Theresa, tissue, twenty, Washington
Valuein 2019 Q1 filing- Value in 2019 Q2 filing
Original filings
Filing view